# EDGAR Filing Document

**Accession Number:** 0001662382
**File Stem:** 0001213900-23-000424
**Filing Date:** 2023-1
**Character Count:** 4249
**Document Hash:** 18615261d915f357754300944e5535ec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-000424.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001213900-23-000424

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20221229

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRAIN SCIENTIFIC INC.
- **CENTRAL INDEX KEY:** 0001662382
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 810876714
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56216
- **FILM NUMBER:** 23502256

**BUSINESS ADDRESS:**
- **STREET 1:** 6700 PROFESSIONAL PARKWAY
- **CITY:** LAKEWOOD RANCH
- **STATE:** FL
- **ZIP:** 34240
- **BUSINESS PHONE:** (646) 388-3788

**MAIL ADDRESS:**
- **STREET 1:** 6700 PROFESSIONAL PARKWAY
- **CITY:** LAKEWOOD RANCH
- **STATE:** FL
- **ZIP:** 34240

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** All Soft Gels Inc
- **DATE OF NAME CHANGE:** 20151229

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

**Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934**

**Date of Report (Date of earliest event reported): December 29, 2022**

**<u>BRAIN SCIENTIFIC INC.</u>**

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-56216** | **81-0876714** |
| **(State or other jurisdiction of <br> incorporation)** | **(Commission File Number)** | **(IRS Employer <br> Identification No.)** |

---

**6700 Professional Parkway**

**Lakewood Ranch, Florida 34240**

**(Address of principal executive offices, including zip code)**

**(917) 388-1578**

**(Registrant's telephone number, including area code)**

Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which<br> registered** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02 Departure of Directors or Certain Officers**

<u>Resignation of Chief Technology Officer</u>

On December 29, 2022, Mr. Fred Anthony submitted to the board of directors of Brain Scientific Inc. (the "Company") his resignation from his position as Chief Technology Officer of the Company, effective December 30, 2022. Mr. Anthony did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **BRAIN SCIENTIFIC INC.** | **BRAIN SCIENTIFIC INC.** |
| Dated: January 3, 2023 | By: | */s/ Hassan Kotob* |
|  |  | Hassan Kotob<br> Chief Executive Officer |

---